Literature DB >> 7806661

Thyroid nodules: clinical effect of ultrasound-guided fine-needle aspiration biopsy.

S Takashima1, H Fukuda, T Kobayashi.   

Abstract

Ultrasound (US)-guided fine-needle aspiration biopsy (FNA) was performed on 268 thyroid nodules (135 palpable, 133 nonpalpable) in 210 patients with various thyroid conditions; 62 nodules also had palpation-guided FNA. Surgical pathology was obtained in 67 malignant nodules and 32 benign nodules. Although the initial failure rate for palpation-guided FNA (12 of 62) was significantly higher than that for US-guided FNA (10 of 268) (p < 0.001), sensitivity (96%), specificity (91%), accuracy (94%), and positive (96%) and negative predictive values (91%) of US-guided FNA for malignancy (n = 99) were not significantly different from those (88%, 90%, 88%, 95%, and 75%, respectively) of palpation-guided FNA (n = 34) for those nodules where an adequate biopsy was obtained. US-guided FNA established a correct diagnosis in 20 of 22 patients with nonpalpable malignancy and in another nodule in the opposite thyroid lobe in 16 of 17 patients with thyroid malignancy. This procedure determined the correct cancer staging in 19 of 21 patients. US-guided FNA can reliably (1) select a patient who needs surgery and (2) avoid unnecessary surgery. This technique will help determine a cancer staging and institute an appropriate treatment.

Entities:  

Mesh:

Year:  1994        PMID: 7806661     DOI: 10.1002/jcu.1870220904

Source DB:  PubMed          Journal:  J Clin Ultrasound        ISSN: 0091-2751            Impact factor:   0.910


  9 in total

1.  Clinical relevance of non-palpable thyroid nodules as assessed by ultrasound-guided fine needle aspiration biopsy.

Authors:  D Nabriski; R Ness-Abramof; T O Brosh; O Konen; M S Shapiro; L Shenkman
Journal:  J Endocrinol Invest       Date:  2003-01       Impact factor: 4.256

Review 2.  A systematic review of ultrasound-guided FNA of lesions in the head and neck--focusing on operator, sample inadequacy and presence of on-spot cytology service.

Authors:  A Ganguly; G Burnside; P Nixon
Journal:  Br J Radiol       Date:  2014-09-23       Impact factor: 3.039

3.  Management of infracentimetric thyroid nodules with respect to ultrasonographic features.

Authors:  Reha Butros; Fatih Boyvat; Umut Ozyer; Banu Bilezikci; Zubeyde Arat; Cuneyt Aytekin; Nilgün Güvener; Beyhan Demirhan
Journal:  Eur Radiol       Date:  2006-09-20       Impact factor: 5.315

4.  The efficiency of performing ultrasound-guided fine-needle aspiration biopsy following mass screening for thyroid tumors to avoid unnecessary surgery.

Authors:  T Kimoto; K Suemitsu; I Eda; T Shimizu; M Ohtani; T Nabika
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

5.  The role of ultrasound in the diagnosis of a large, rapidly growing, thyroid mass.

Authors:  A D King; A T Ahuja; W King; C Metreweli
Journal:  Postgrad Med J       Date:  1997-07       Impact factor: 2.401

Review 6.  Evidence-based assessment of the role of ultrasonography in the management of benign thyroid nodules.

Authors:  Lilah F Morris; Nagesh Ragavendra; Michael W Yeh
Journal:  World J Surg       Date:  2008-07       Impact factor: 3.352

7.  Ultrasound-guided fine-needle aspiration biopsy in unselected consecutive patients with thyroid nodules.

Authors:  Zdravko A Kamenov; Vera N Karamfilova; Georgi N Chavrakov
Journal:  ISRN Endocrinol       Date:  2011-07-14

8.  Diagnostic accuracy of palpation versus ultrasound-guided fine needle aspiration biopsy for diagnosis of malignancy in thyroid nodules: a systematic review and meta-analysis.

Authors:  Tri Juli Edi Tarigan; Budiman Syaeful Anwar; Robert Sinto; Wismandari Wisnu
Journal:  BMC Endocr Disord       Date:  2022-07-17       Impact factor: 3.263

9.  Thyroid nodule with benign cytology: is clinical follow-up enough?

Authors:  Yoon Jung Choi; Inkyung Jung; Sung Ji Min; Hye Jung Kim; Ji-Hoon Kim; Soojin Kim; Jeong Seon Park; Jung Hee Shin; Yu-Mee Sohn; Jung Hyun Yoon; Jin Young Kwak
Journal:  PLoS One       Date:  2013-05-24       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.